Omeros | OMER - Le Bénéfice D'Exploitation

Prix De L'Action
12.25
Variation Quotidienne
-1.03 -7.76%
Mensuellement
-2.31%
Annuel
281.03%
Q2 Prévisions
12.00




Le Bénéfice D'Exploitation Changement Date
Adma Biologics USD 62.75M 11.74M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Cytokinetics USD -181.23M 2.86M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
Rockwell Medical USD 515K 1.84M 2024-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xoma USD -15.64M 5.56M 2024-09